PL368505A1 - Zapobieganie uzależnieniom przy terapii przeciwbólowej - Google Patents

Zapobieganie uzależnieniom przy terapii przeciwbólowej

Info

Publication number: PL368505A1
Authority: PL; Poland
Prior art keywords: addiction; prevention; pain management; eliminating; reducing
Prior art date: 2001-05-14

Application number

PL02368505A

Other languages

English (en)

Inventor

Stephen L. Dewey

Jonathan D. Brodie

Charles R.Jr. Ashby

Original Assignee

Brookhaven Science Associates

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-05-14

Filing date

2002-04-08

Publication date

2005-04-04

2002-04-08 Application filed by Brookhaven Science Associates filed Critical Brookhaven Science Associates

2005-04-04 Publication of PL368505A1 publication Critical patent/PL368505A1/pl

Links

206010012335 Dependence Diseases 0.000 title 1
230000002265 prevention Effects 0.000 title 1
230000000202 analgesic effect Effects 0.000 abstract 2
239000003445 gaba agent Substances 0.000 abstract 1
PJDFLNIOAUIZSL-UHFFFAOYSA-N vigabatrin Chemical compound C=CC(N)CCC(O)=O PJDFLNIOAUIZSL-UHFFFAOYSA-N 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Biomedical Technology (AREA)
Addiction (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Psychiatry (AREA)
Pain & Pain Management (AREA)
Emergency Medicine (AREA)
Rheumatology (AREA)
Toxicology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

PL02368505A 2001-05-14 2002-04-08 Zapobieganie uzależnieniom przy terapii przeciwbólowej PL368505A1 (pl)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US09/853,548 US20020187996A1 (en)	2001-05-14	2001-05-14	Prevention of addiction in pain management

Publications (1)

Publication Number	Publication Date
PL368505A1 true PL368505A1 (pl)	2005-04-04

Family

ID=25316324

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL02368505A PL368505A1 (pl)	2001-05-14	2002-04-08	Zapobieganie uzależnieniom przy terapii przeciwbólowej

Country Status (21)

Country	Link
US (3)	US20020187996A1 (pl)
EP (1)	EP1392301B1 (pl)
JP (1)	JP2004534029A (pl)
KR (1)	KR20040020054A (pl)
CN (1)	CN100528156C (pl)
AT (1)	ATE473001T1 (pl)
AU (1)	AU2002342533B2 (pl)
BR (1)	BR0209613A (pl)
CA (1)	CA2446639C (pl)
CZ (1)	CZ20033380A3 (pl)
DE (1)	DE60236927D1 (pl)
ES (1)	ES2348637T3 (pl)
HR (1)	HRP20030892A2 (pl)
HU (1)	HUP0402326A3 (pl)
IL (1)	IL158762A0 (pl)
MX (1)	MXPA03010407A (pl)
NO (1)	NO331509B1 (pl)
NZ (1)	NZ529614A (pl)
PL (1)	PL368505A1 (pl)
WO (1)	WO2002091990A2 (pl)
YU (1)	YU89003A (pl)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE60133203T3 (de) *	2000-07-31	2012-02-23	Nycomed Danmark Aps	Fentanyl Zusammensetzung für nasale Anwendung
DE10141650C1 (de)	2001-08-24	2002-11-28	Lohmann Therapie Syst Lts	Transdermales Therapeutisches System mit Fentanyl bzw. verwandten Substanzen
US20050043345A1 (en) *	2003-08-22	2005-02-24	Pfizer Inc	Pharmaceutical composition for the prevention and treatment of addiction in a mammal
US8652527B1 (en)	2013-03-13	2014-02-18	Upsher-Smith Laboratories, Inc	Extended-release topiramate capsules
US9101545B2 (en)	2013-03-15	2015-08-11	Upsher-Smith Laboratories, Inc.	Extended-release topiramate capsules
CN105497896A (zh) *	2015-03-31	2016-04-20	苏州大学	一种肿瘤耐药的靶点及其应用
WO2022119430A1 (es)	2020-12-04	2022-06-09	Laboratorios Silanes S.A. De C.V.	Composición farmacéutica sólida recubierta y estable de un analgésico opioide y un antiepiléptico para el dolor
US11977085B1 (en)	2023-09-05	2024-05-07	Elan Ehrlich	Date rape drug detection device and method of using same

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6057368A (en) *	1998-08-05	2000-05-02	Brookhaven Science Associates Llc	Treatment of addiction and addiction-related behavior
US6541520B1 (en) *	1998-08-05	2003-04-01	Brookhaven Science Associates	Treatment of addiction and addiction-related behavior

2001
- 2001-05-14 US US09/853,548 patent/US20020187996A1/en not_active Abandoned
2002
- 2002-04-08 CN CNB028098277A patent/CN100528156C/zh not_active Expired - Fee Related
- 2002-04-08 CZ CZ20033380A patent/CZ20033380A3/cs unknown
- 2002-04-08 WO PCT/US2002/011072 patent/WO2002091990A2/en not_active Ceased
- 2002-04-08 HU HU0402326A patent/HUP0402326A3/hu unknown
- 2002-04-08 BR BR0209613-7A patent/BR0209613A/pt not_active IP Right Cessation
- 2002-04-08 JP JP2002588909A patent/JP2004534029A/ja active Pending
- 2002-04-08 EP EP02769652A patent/EP1392301B1/en not_active Expired - Lifetime
- 2002-04-08 AT AT02769652T patent/ATE473001T1/de not_active IP Right Cessation
- 2002-04-08 MX MXPA03010407A patent/MXPA03010407A/es not_active Application Discontinuation
- 2002-04-08 PL PL02368505A patent/PL368505A1/pl not_active Application Discontinuation
- 2002-04-08 AU AU2002342533A patent/AU2002342533B2/en not_active Ceased
- 2002-04-08 DE DE60236927T patent/DE60236927D1/de not_active Expired - Lifetime
- 2002-04-08 HR HR20030892A patent/HRP20030892A2/xx not_active Application Discontinuation
- 2002-04-08 KR KR10-2003-7014736A patent/KR20040020054A/ko not_active Withdrawn
- 2002-04-08 CA CA2446639A patent/CA2446639C/en not_active Expired - Fee Related
- 2002-04-08 YU YU89003A patent/YU89003A/sh unknown
- 2002-04-08 ES ES02769652T patent/ES2348637T3/es not_active Expired - Lifetime
- 2002-04-08 IL IL15876202A patent/IL158762A0/xx unknown
- 2002-04-08 NZ NZ529614A patent/NZ529614A/en unknown
- 2002-04-18 US US10/124,660 patent/US6939876B2/en not_active Expired - Fee Related
2003
- 2003-01-02 US US10/335,800 patent/US20030134868A1/en not_active Abandoned
- 2003-11-13 NO NO20035038A patent/NO331509B1/no not_active IP Right Cessation

Also Published As

Publication number	Publication date
CN1531431A (zh)	2004-09-22
BR0209613A (pt)	2004-12-07
US20030004176A1 (en)	2003-01-02
HUP0402326A2 (hu)	2005-02-28
US20020187996A1 (en)	2002-12-12
EP1392301A2 (en)	2004-03-03
JP2004534029A (ja)	2004-11-11
CA2446639A1 (en)	2002-11-21
YU89003A (sh)	2006-08-17
HUP0402326A3 (en)	2008-04-28
US6939876B2 (en)	2005-09-06
WO2002091990A2 (en)	2002-11-21
EP1392301B1 (en)	2010-07-07
CN100528156C (zh)	2009-08-19
MXPA03010407A (es)	2004-05-05
NO20035038D0 (no)	2003-11-13
US20030134868A1 (en)	2003-07-17
KR20040020054A (ko)	2004-03-06
DE60236927D1 (de)	2010-08-19
NO331509B1 (no)	2012-01-16
WO2002091990A3 (en)	2003-03-27
AU2002342533B2 (en)	2007-07-05
HRP20030892A2 (en)	2005-08-31
CA2446639C (en)	2010-11-02
EP1392301A4 (en)	2004-07-14
ES2348637T3 (es)	2010-12-10
IL158762A0 (en)	2004-05-12
NZ529614A (en)	2006-08-31
ATE473001T1 (de)	2010-07-15
CZ20033380A3 (cs)	2005-03-16

Legal Events

Date	Code	Title	Description
2010-10-29	REFS	Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)

Publication	Publication Date	Title
MXPA05003501A (es)	2005-10-19	Metodos para tratamiento del dolor administrando un antagonista del factor de crecimiento del nervio y un analgesico opioide y composiciones que los contienen.
WO2004091540A3 (en)	2006-02-02	Methods of treating pain and compositions for use therefor
WO2002053187A3 (en)	2008-01-17	Methods and transdermal compositions for pain relief
SI1509232T1 (sl)	2009-04-30	Kombinacija antagonista nmda in zaviralcev acetilholinesteraze za zdravljenje alzheimerjeve bolezni
DE60128912D1 (en)	2007-07-26	Pyridoxin- und pyridoxalanaloga als cardiovasculäre therapeutika
EP1553951A4 (en)	2008-06-11	COMPOSITIONS CONTAINING A JNK INHIBITOR FOR TREATING, PREVENTING, MANAGING AND / OR MODIFYING PAIN, AND METHODS OF USE THEREOF
WO2003059254A3 (en)	2004-02-12	Prevention and treatment of atherosclerosis and restenosis
IL158762A0 (en)	2004-05-12	Prevention of addiction in pain management
MY137620A (en)	2009-02-27	Therapeutic treatment
EP1441718A4 (en)	2005-08-17	CARBINOL FOR THE TREATMENT OF NEUROPATHIC FUNCTIONAL DISORDER
MY122838A (en)	2006-05-31	Treating allergic and inflammatory conditions
GB0201367D0 (en)	2002-03-13	Composition
WO2003015690A3 (en)	2003-09-25	Method for treating primary insomnia
WO1999065475A3 (en)	2000-04-06	Combination of phentolamine and apomorphine for the treatment of human sexual function and dysfunction
MY126321A (en)	2006-09-29	Use of (alpha)-adrenoreceptor antagonists in the prevention and treatment of cancer.
WO2007006732A8 (en)	2008-01-24	Synergistic combination for the treatment of pain (cannabioid receptor agonist and opiod receptor agonist)
AU2001280093A1 (en)	2002-02-25	Method for the prevention and treatment of retinopathy
IL166596A0 (en)	2006-01-15	Salt of morphine-6-glucoronide
MXPA04004075A (es)	2004-07-23	Compuesto y metodo para tratamiento de vejiga hiperactiva.
MXPA04010915A (es)	2006-03-08	Base y procedimiento de conocimiento de recursos humanos dinamicos.
AU4937499A (en)	2000-09-21	Use of succinic acid or salts thereof and method of treating insulin resistance
EP1260221A3 (en)	2002-12-18	Combination treatment for depression and anxiety
AU2003275433A8 (en)	2004-05-04	Compositions and methods for treating pain
EP1487427A4 (en)	2006-01-18	METHODS FOR PREVENTING AND TREATING PERIPHERAL NEUROPATHY BY ADMINISTERING DESMETHYLSELEGILINE
TW200501958A (en)	2005-01-16	A therapeutic agent for treating a behavioral disorder